Page last updated: 2024-08-26

4-hydroxycyclophosphamide and indazoles

4-hydroxycyclophosphamide has been researched along with indazoles in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ma, J; Waxman, DJ	1
Blute, T; Chen, CS; Ma, J; Waxman, DJ	1

Other Studies

2 other study(ies) available for 4-hydroxycyclophosphamide and indazoles

Article	Year
Dominant effect of antiangiogenesis in combination therapy involving cyclophosphamide and axitinib. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-15, Volume: 15, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Benzimidazoles; Cell Line, Tumor; Cyclophosphamide; Genes, Dominant; Humans; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neoplasm Transplantation; Prostatic Neoplasms	2009
Antiangiogenesis enhances intratumoral drug retention. Cancer research, 2011, Apr-01, Volume: 71, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Gliosarcoma; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neovascularization, Pathologic; Random Allocation; Rats; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous	2011

Article

Year

Dominant effect of antiangiogenesis in combination therapy involving cyclophosphamide and axitinib.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-15, Volume: 15, Issue:2

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Benzimidazoles; Cell Line, Tumor; Cyclophosphamide; Genes, Dominant; Humans; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neoplasm Transplantation; Prostatic Neoplasms

2009

Antiangiogenesis enhances intratumoral drug retention.

Cancer research, 2011, Apr-01, Volume: 71, Issue:7

Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Gliosarcoma; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neovascularization, Pathologic; Random Allocation; Rats; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous

2011